CuraCell TX AB
European biotech developing personalized T-cell therapies for solid cancer tumors.
Översikt
- 5
- Anställda
- 45t SEK
- Omsättning
- 2020
- Grundat
Nyckelbeslutsfattare
Håkan Hallberg
CFO
Lucas Arruda
Chief Scientific Officer
Thomas Schlegel
General Counsel
Thomas Jaecklin
Board Member
+6 fler kontakter i Funnelfeedr
Beskrivning
CuraCell is a European biotech company focused on developing innovative T-cell therapies for the treatment of solid cancer tumors. The company utilizes its proprietary platform, CytoPLY, designed to significantly expand and activate the patient's own tumor-reactive T-cells. Their primary therapeutic...
Taggar
Nyckelord
Teknikstack
Företagsinformation
- Bransch
- Bioteknisk forskning och utveckling
- Juridisk form
- Aktiebolag
- Momsnummer
- SE559280854601
Beslutsfattare
10 kontakter i FunnelfeedrHåkan Hallberg
CFO
Lucas Arruda
Chief Scientific Officer
Thomas Schlegel
General Counsel
Thomas Jaecklin
Board Member
Jonas Båtelson
CEO & Co-founder
Martin Forster
Board Member
Martina Ochel
COO
Per-Henrik Holmqvist
Head of CMC
Torbjörn Ström
Head of Clinical Operations
Agnes Asp Sandin
Data Protection Officer
Liknande företag
20 liknande företag i Funnelfeedr
Ultimovacs AB
0 anställdaPioneering off-the-shelf TCR-NK cell therapies to cure solid cancers.
Anocca AB
100–199 anställdaEngineering precision T-cell immunotherapies for hard-to-treat cancers.
SeqCure Immunology AB
1 anställdaDeveloping personalized, non-genetically engineered cell therapy for advanced cancer.
ZELLUNA ASA
7 anställdaPioneering TCR-NK cell therapies to eliminate solid cancers effectively.
ZELLUNA IMMUNOTHERAPY AS
9 anställdaPioneering TCR-NK cell therapies to eliminate solid cancers safely.
Frågor om CuraCell TX AB
Vill du se Funnelfeedr i praktiken?
Boka en gratis demo och upptäck hur Funnelfeedr hjälper dig att hitta och konvertera dina idealkunder.
Boka en demo